Immunotherapy Is Fastest Growing Segment Fueling The Growth Of Cancer Biologics Market

https://www.coherentmarketinsights.com/market-insight/cancer-biologics-market-4145



The global Cancer Biologics Market is estimated to be valued at US$ 94.5 Bn in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview
Cancer biologics are drugs used for treating cancer that utilize living systems, especially the immune system, to fight cancer. They work with the body's natural defenses to target and kill cancer cells. Cancer biologics provide targeted treatment options with less harmful side effects than chemotherapy or radiation for some cancer patients.

Market key trends

The global cancer biologics market is witnessing robust growth due to rising demand for immunotherapies. Immunotherapy utilizes the body's own immune system to fight cancer by boosting the immune response or by correcting immune dysfunctions. Immunotherapies like checkpoint inhibitors, immune system modulators, monoclonal antibodies and cancer vaccines are fast becoming the standard of care for treating various types of cancer like lung cancer and melanoma. Their ability to produce long-lasting remission with minimal toxicity compared to chemotherapy has fueled their adoption in recent years.

Segment Analysis

The global cancer biologics market is segmented based on products, therapeutic area and end user. Based on products, the market is segmented into monoclonal antibodies, vaccines and cell & gene therapies. Among these, monoclonal antibodies segment currently dominates the market owing to the increasing number of approvals and launch of novel monoclonal antibody drugs. Some of the blockbuster monoclonal antibody drugs available in the market include Avastin, Herceptin, Rituxan and Opdivo.

Key Takeaways

The global Cancer Biologics Market Demand is expected to witness high growth, exhibiting CAGR of 4.6% over the forecast period, due to the increasing prevalence of cancer worldwide. The global cancer biologics market size for 2023 is US$ 94.5 Bn.

Regional analysis: North America currently dominates the global cancer biologics market owing to the presence of advanced healthcare infrastructure and high adoption of novel biologics drugs in the region. Asia Pacific is expected to exhibit the fastest growth during the forecast period attributed to the increasing healthcare spending and rising awareness regarding cancer biologics therapies.

Key players: Key players operating in the cancer biologics market are F. Hoffmann-La Roche Ltd., Amgen, Inc., Pfizer, Inc., GSK plc., Bristol-Myers Squibb Company, Abbott, AstraZeneca, Eli Lilly and Company, Gilead Sciences, Inc., and Johnson & Johnson Services, Inc. These players are focusing on developing novel biologics through partnerships and acquisitions to strengthen their product portfolio.


Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease

Image
U.S. Sterile Injectables Market    Sterile Injectables are compounded medications with sterile components for intravenous administration. They are composed of small molecules, large molecules, and biologics. In 2018, the global sterile injectable market was valued at US$ 357 billion. During the forecast period, the market is expected to grow at a 7.3% CAGR. The market will likely be driven by the growing demand for these medications in developing countries. The U.S. sterile injectables market is expected to expand over the forecast period due to rising product launches are one of the key factors boosting the growth of this market. Many sterile products fail to meet regulatory requirements. Due to the risk involved, a sterile drug product must meet strict standards. Lack of quality assurance in the manufacturing process can result in low-quality medicines. To combat this risk, manufacturers highly trust CMOs to adhere to rigorous quality standards. Manufacturers of sterile injectables a
Read more